Literature DB >> 12475607

Emerging functions for tuberoinfundibular peptide of 39 residues.

Ted B Usdin1, Arpad Dobolyi, Hiroshi Ueda, Miklós Palkovits.   

Abstract

Tuberoinfundibular peptide of 39 residues (TIP39), a neuropeptide recently purified from the hypothalamus, appears to be an endogenous ligand for the parathyroid hormone 2 (PTH2) receptor. PTH2 receptors are present in several central nervous system and peripheral areas and are particularly concentrated in the hypothalamus, limbic areas and the outer layers of the spinal cord dorsal horn. TIP39-containing neuronal cell bodies have been identified in the subparafascicular area and the medial paralemniscal nucleus, two brainstem regions that project widely through the entire neuraxis. Treatment of hypothalamic explants with TIP39, and intraventricular injection of the peptide, suggest that it might stimulate hypothalamic-releasing factor secretion. Injection of TIP39, and sequestration of endogenous TIP39 by intrathecal injection of an antibody to TIP39, have provided evidence that it is involved in some aspects of pain sensitivity. Thus, TIP39 might be a new neuromodulator.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12475607     DOI: 10.1016/s1043-2760(02)00002-4

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  18 in total

1.  Postnatal development and gender-dependent expression of TIP39 in the rat brain.

Authors:  Arpád Dobolyi; Jing Wang; Sarah Irwin; Ted Björn Usdin
Journal:  J Comp Neurol       Date:  2006-09-20       Impact factor: 3.215

2.  Tuberoinfundibular peptide of 39 residues- immunoreactive fibers in the zona incerta and the supraoptic decussations terminate in the neuroendocrine hypothalamus.

Authors:  M Palkovits; T B Usdin; G B Makara; A Dobolyi
Journal:  Neurochem Res       Date:  2010-10-24       Impact factor: 3.996

Review 3.  Structure of Class B GPCRs: new horizons for drug discovery.

Authors:  Andrea Bortolato; Andrew S Doré; Kaspar Hollenstein; Benjamin G Tehan; Jonathan S Mason; Fiona H Marshall
Journal:  Br J Pharmacol       Date:  2014-07       Impact factor: 8.739

4.  Tuberoinfundibular peptide of 39 residues is activated during lactation and participates in the suckling-induced prolactin release in rat.

Authors:  Melinda Cservenák; Ibolya Bodnár; Ted B Usdin; Miklós Palkovits; György M Nagy; Arpád Dobolyi
Journal:  Endocrinology       Date:  2010-09-22       Impact factor: 4.736

5.  The distribution and neurochemistry of the parathyroid hormone 2 receptor in the rat hypothalamus.

Authors:  Arpád Dobolyi; Sarah Irwin; Jing Wang; Ted Björn Usdin
Journal:  Neurochem Res       Date:  2006-03-29       Impact factor: 3.996

6.  Acoustic stress activates tuberoinfundibular peptide of 39 residues neurons in the rat brain.

Authors:  Miklós Palkovits; Frigyes Helfferich; Arpád Dobolyi; Ted B Usdin
Journal:  Brain Struct Funct       Date:  2009-11-21       Impact factor: 3.270

7.  Parathyroid hormone 2 receptor and its endogenous ligand tuberoinfundibular peptide of 39 residues are concentrated in endocrine, viscerosensory and auditory brain regions in macaque and human.

Authors:  A G Bagó; E Dimitrov; R Saunders; L Seress; M Palkovits; T B Usdin; A Dobolyi
Journal:  Neuroscience       Date:  2009-05-03       Impact factor: 3.590

8.  Distribution of tuberoinfundibular peptide of 39 residues and its receptor, parathyroid hormone 2 receptor, in the mouse brain.

Authors:  Catherine A Faber; Arpád Dobolyi; Mark Sleeman; Ted B Usdin
Journal:  J Comp Neurol       Date:  2007-06-01       Impact factor: 3.215

9.  Parathyroid hormone 2 receptor is a functional marker of nociceptive myelinated fibers responsible for neuropathic pain.

Authors:  Misaki Matsumoto; Saori Kondo; Ted B Usdin; Hiroshi Ueda
Journal:  J Neurochem       Date:  2009-11-05       Impact factor: 5.372

10.  Allosteric modulators of class B G-protein-coupled receptors.

Authors:  Sam R J Hoare
Journal:  Curr Neuropharmacol       Date:  2007-09       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.